A facilitated access program to provide Everolimus (RAD) for maintenance for patients completing therapy in RAD trials in solid organ transplantation

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-001473-25

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

• To facilitate the management of patients on maintenance immunosuppression therapy who are completing everolimus trials, • To provide everolimus maintenance therapy through this access program and • To collect and review safety data until drug is commercially available or the project has been discontinued.


Critère d'inclusion

  • Solid organ transplantation